{"BioModel":{"$":{"name":"PLACEHOLDER"},"math":[],"text":[{"$":{"name":"Species(species_18)"},"_":"<notes>\r\n          <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n            <pre>Degraded species of EGFR; Initial value estimated from experiments</pre>\r\n          </body>\r\n        </notes>"},{"$":{"name":"ReactionStep(EGFReceptor_Degradtion_Free)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n    <pre>Parameters were estimated from experiments</pre>\r\n  </body>\r\n</html>\r\n"},{"$":{"name":"ReactionStep(EGFReceptor_Production)"},"_":"<notes>\r\n          <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n            <pre>Parameters were estimated from experiments</pre>\r\n          </body>\r\n        </notes>"},{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n    <div class=\"dc:title\">\r\n      This model is based on Orton et al., 2009 paper &quot;\r\n    </div>\r\n    <div class=\"dc:title\">\r\n      Modelling cancerous mutations in the EGFR/ERK pathway&quot; that studies the \r\n      aberrations in ERK signalling for different cancer mutations. The \r\n      authors alter a previously existing EGF model (Brown et al 2004) to \r\n      include new interactions that better fit empirical data. Predictions \r\n      show that the ERK signalling is a robust mechanism taking different \r\n      courses for different cancer mutations. Most parameter values are used \r\n      from the previous model and the new parameters are estimated using \r\n      experimental data performed by the authors on PC12 cells (adrenal gland, \r\n      rat). The authors provide an SBML version of the model in the paper.\r\n    </div>\r\n    <div class=\"dc:bibliographicCitation\">\r\n      <p>\r\n        This model is described in the article:\r\n      </p>\r\n      <div class=\"bibo:title\">\r\n        <a title=\"Access to this publication\" href=\"http://identifiers.org/pubmed/19804630\">Computational \r\n        modelling of cancerous mutations in the EGFR/ERK signalling pathway.</a>\r\n      </div>\r\n      <div class=\"bibo:authorList\">\r\n        Orton RJ, Adriaens ME, Gormand A, Sturm OE, Kolch W, Gilbert DR.\r\n      </div>\r\n      <div class=\"bibo:Journal\">\r\n        BMC Syst Biol 2009 Oct; 3: 100\r\n      </div>\r\n      <p>\r\n        Abstract:\r\n      </p>\r\n      <div class=\"bibo:abstract\">\r\n        <p>\r\n          The Epidermal Growth Factor Receptor (EGFR) activated \r\n          Extracellular-signal Regulated Kinase (ERK) pathway is a critical \r\n          cell signalling pathway that relays the signal for a cell to \r\n          proliferate from the plasma membrane to the nucleus. Deregulation of \r\n          the EGFR/ERK pathway due to alterations affecting the expression or \r\n          function of a number of pathway components has long been associated \r\n          with numerous forms of cancer. Under normal conditions, Epidermal \r\n          Growth Factor (EGF) stimulates a rapid but transient activation of \r\n          ERK as the signal is rapidly shutdown. Whereas, under cancerous \r\n          mutation conditions the ERK signal cannot be shutdown and is \r\n          sustained resulting in the constitutive activation of ERK and \r\n          continual cell proliferation. In this study, we have used \r\n          computational modelling techniques to investigate what effects \r\n          various cancerous alterations have on the signalling flow through \r\n          the ERK pathway.We have generated a new model of the EGFR activated \r\n          ERK pathway, which was verified by our own experimental data. We \r\n          then altered our model to represent various cancerous situations \r\n          such as Ras, B-Raf and EGFR mutations, as well as EGFR \r\n          overexpression. Analysis of the models showed that different \r\n          cancerous situations resulted in different signalling patterns \r\n          through the ERK pathway, especially when compared to the normal EGF \r\n          signal pattern. Our model predicts that cancerous EGFR mutation and \r\n          overexpression signals almost exclusively via the Rap1 pathway, \r\n          predicting that this pathway is the best target for drugs. \r\n          Furthermore, our model also highlights the importance of receptor \r\n          degradation in normal and cancerous EGFR signalling, and suggests \r\n          that receptor degradation is a key difference between the signalling \r\n          from the EGF and Nerve Growth Factor (NGF) receptors.Our results \r\n          suggest that different routes to ERK activation are being utilised \r\n          in different cancerous situations which therefore has interesting \r\n          implications for drug selection strategies. We also conducted a \r\n          comparison of the critical differences between signalling from \r\n          different growth factor receptors (namely EGFR, mutated EGFR, NGF, \r\n          and Insulin) with our results suggesting the difference between the \r\n          systems are large scale and can be attributed to the \r\n          presence/absence of entire pathways rather than subtle difference in \r\n          individual rate constants between the systems.\r\n        </p>\r\n      </div>\r\n    </div>\r\n    <div class=\"dc:publisher\">\r\n      <p>\r\n        This model is hosted on <a href=\"http://www.ebi.ac.uk/biomodels/\">BioModels \r\n        Database</a> and identified by: <a href=\"http://identifiers.org/biomodels.db/BIOMD0000000623\">BIOMD0000000623</a>.\r\n      </p>\r\n      <p>\r\n        To cite BioModels Database, please use: <a title=\"Latest BioModels Database publication\" href=\"http://identifiers.org/pubmed/20587024\">BioModels \r\n        Database: An enhanced, curated and annotated resource for published \r\n        quantitative kinetic models</a>.\r\n      </p>\r\n    </div>\r\n    <div class=\"dc:license\">\r\n      <p>\r\n        To the extent possible under law, all copyright and related or \r\n        neighbouring rights to this encoded model have been dedicated to the \r\n        public domain worldwide. Please refer to <a title=\"Access to: CC0 1.0 Universal (CC0 1.0), Public Domain Dedication\" href=\"http://creativecommons.org/publicdomain/zero/1.0/\">CC0 \r\n        Public Domain Dedication</a> for more information.\r\n      </p>\r\n    </div>\r\n  </body>\r\n</html>\r\n"},{"$":{"name":"Species(species_25)"},"_":"<notes>\r\n          <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n            <pre>Epidermal Growth Factor; Initial value taken from Brown et al 2004</pre>\r\n          </body>\r\n        </notes>"},{"$":{"name":"SimulationContext(Deterministic)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n  </body>\r\n</html>\r\n"},{"$":{"name":"ReactionStep(EGF_Binding_Unbinding)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n    <pre>Parameters taken from Brown et al 2004</pre>\r\n  </body>\r\n</html>\r\n"},{"$":{"name":"Species(species_1)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n    <pre>Free EGF receptor; Initial value taken from Brown et al 2004</pre>\r\n  </body>\r\n</html>\r\n"},{"$":{"name":"Species(species_0)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n    <pre>EGFR Receptor bound to EGF; Initial value was estimated from experiments</pre>\r\n  </body>\r\n</html>\r\n"},{"$":{"name":"ReactionStep(EGFReceptor_Degradation)"},"_":"<notes>\r\n          <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n            <pre>Parameters were estimated from experiments</pre>\r\n          </body>\r\n        </notes>"},{"$":{"name":"Species(species_30)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n    <pre>Species preceding active EGF receptor; Initial value estimated from experiments</pre>\r\n  </body>\r\n</html>\r\n"},{"$":{"name":"Structure(PC12_cell)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body>\r\n    <span align=\"left\" style=\"letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; background-color: rgb(245, 250, 250); display: inline !important; float: none\"><font color=\"rgb(35, 73, 121)\" face=\"Lucida Sans Unicode, Lucida Grande, sans-serif\" size=\"12px\">Rat \r\n    adrenal pheochromocytoma established from a transplantable rat adrenal \r\n    pheochromocytoma in 1976; cells were described to synthesize \r\n    catecholamines (dopamine, norepinephrine); in response to nerve growth \r\n    factor (NGF) a neuronal phenotype could be induced reversibly.</font></span>\r\n  </body>\r\n</html>\r\n"},{"$":{"name":"MolecularType(EGFR)"},"_":"<html>\r\n  <head>\r\n    \r\n  </head>\r\n  <body xmlns=\"http://www.w3.org/1999/xhtml\">\r\n  </body>\r\n</html>\r\n"}],"url":{"http://www.sbml.org/sbml/level2/version4/COPASI33":{"$":{"name":"ReactionStep(EGF_Binding_Unbinding)"},"_":"","vcid":"ReactionStep(EGF_Binding_Unbinding)"},"http://www.sbml.org/sbml/level2/version4/COPASI20":{"$":{"name":"Species(species_18)"},"_":"","vcid":"Species(species_18)"},"http://www.sbml.org/sbml/level2/version4/COPASI1":{"$":{"name":"Structure(PC12_cell)"},"_":"","vcid":"Structure(PC12_cell)"},"http://www.sbml.org/sbml/level2/version4/COPASI53":{"$":{"name":"ReactionStep(EGFReceptor_Degradation)"},"_":"","vcid":"ReactionStep(EGFReceptor_Degradation)"},"http://www.sbml.org/sbml/level2/version4/COPASI61":{"$":{"name":"ReactionStep(EGFReceptor_Production)"},"_":"","vcid":"ReactionStep(EGFReceptor_Production)"},"http://sourceforge.net/projects/vcell/vcml/org.vcell.model.rbm.MolecularType/metaid_2032412072":{"$":{"name":"MolecularType(EGFR)"},"_":"","vcid":"MolecularType(EGFR)"},"http://www.sbml.org/sbml/level2/version4/COPASI27":{"$":{"name":"Species(species_25)"},"_":"","vcid":"Species(species_25)"},"http://www.sbml.org/sbml/level2/version4/COPASI62":{"$":{"name":"ReactionStep(EGFReceptor_Degradtion_Free)"},"_":"","vcid":"ReactionStep(EGFReceptor_Degradtion_Free)"},"http://www.sbml.org/sbml/level2/version4/COPASI2":{"$":{"name":"Species(species_0)"},"_":"","vcid":"Species(species_0)"},"http://www.sbml.org/sbml/level2/version4/COPASI0":{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"","vcid":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"http://sourceforge.net/projects/vcell/vcml/org.vcell.model.rbm.MolecularType/metaid_2118622770":{"$":{"name":"MolecularType(EGF)"},"_":"","vcid":"MolecularType(EGF)"},"http://www.sbml.org/sbml/level2/version4/COPASI3":{"$":{"name":"Species(species_1)"},"_":"","vcid":"Species(species_1)"},"http://www.sbml.org/sbml/level2/version4/COPASI32":{"$":{"name":"Species(species_30)"},"_":"","vcid":"Species(species_30)"},"$1MolecularType(EGFR)":{"$":{"name":"MolecularType(EGFR)"},"_":"urn:miriam:chebi:CHEBI%3A74440","vcid":"MolecularType(EGFR)","qualifier":"(bio) hasVersion"},"$2MolecularType(EGFR)":{"$":{"name":"MolecularType(EGFR)"},"_":"urn:miriam:uniprot:Q9QX70","vcid":"MolecularType(EGFR)","qualifier":"(bio) isDescribedBy"},"$1MolecularType(EGF)":{"$":{"name":"MolecularType(EGF)"},"_":"urn:miriam:uniprot:P07522","vcid":"MolecularType(EGF)","qualifier":"(bio) isDescribedBy"},"$1BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)":{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"http://identifiers.org/doid/DOID:162","vcid":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)","qualifier":"(bio) hasProperty"},"$2BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)":{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"http://identifiers.org/taxonomy/10116","vcid":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)","qualifier":"(bio) hasTaxon"},"$3BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)":{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"http://identifiers.org/go/GO:0007173","vcid":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)","qualifier":"(bio) isVersionOf"},"$4BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)":{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"http://identifiers.org/bto/BTO:0001009","vcid":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)","qualifier":"(bio) occursIn"},"$5BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)":{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"http://identifiers.org/biomodels.db/MODEL1611280000","vcid":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)","qualifier":"(model) is"},"$6BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)":{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"http://identifiers.org/biomodels.db/BIOMD0000000033","vcid":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)","qualifier":"(model) isDerivedFrom"},"$7BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)":{"$":{"name":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)"},"_":"http://identifiers.org/pubmed/19804630","vcid":"BioModel(CM_PM19804630_MB1::Initial_events_EGFR_signaling)","qualifier":"(model) isDescribedBy"},"$1Structure(PC12_cell)":{"$":{"name":"Structure(PC12_cell)"},"_":"urn:miriam:bto:BTO%3A0001009","vcid":"Structure(PC12_cell)","qualifier":"(bio) isDescribedBy"},"$2Structure(PC12_cell)":{"$":{"name":"Structure(PC12_cell)"},"_":"http://identifiers.org/go/GO:0005623","vcid":"Structure(PC12_cell)","qualifier":"(model) is"},"$1Species(species_0)":{"$":{"name":"Species(species_0)"},"_":"urn:miriam:chebi:CHEBI%3A74440","vcid":"Species(species_0)","qualifier":"(bio) hasVersion"},"$2Species(species_0)":{"$":{"name":"Species(species_0)"},"_":"http://identifiers.org/uniprot/Q9QX70","vcid":"Species(species_0)","qualifier":"(bio) isVersionOf"},"$1Species(species_18)":{"$":{"name":"Species(species_18)"},"_":"http://identifiers.org/uniprot/Q9QX70","vcid":"Species(species_18)","qualifier":"(bio) isVersionOf"},"$1Species(species_25)":{"$":{"name":"Species(species_25)"},"_":"http://identifiers.org/uniprot/P07522","vcid":"Species(species_25)","qualifier":"(bio) isVersionOf"},"$1Species(species_1)":{"$":{"name":"Species(species_1)"},"_":"urn:miriam:chebi:CHEBI%3A74440","vcid":"Species(species_1)","qualifier":"(bio) hasVersion"},"$2Species(species_1)":{"$":{"name":"Species(species_1)"},"_":"http://identifiers.org/uniprot/Q9QX70","vcid":"Species(species_1)","qualifier":"(bio) isVersionOf"},"$1Species(species_30)":{"$":{"name":"Species(species_30)"},"_":"http://identifiers.org/uniprot/Q9QX70","vcid":"Species(species_30)","qualifier":"(bio) isVersionOf"},"$1ReactionStep(EGF_Binding_Unbinding)":{"$":{"name":"ReactionStep(EGF_Binding_Unbinding)"},"_":"http://identifiers.org/sbo/SBO:0000012","vcid":"ReactionStep(EGF_Binding_Unbinding)","qualifier":"(bio) is"},"$1ReactionStep(EGFReceptor_Degradation)":{"$":{"name":"ReactionStep(EGFReceptor_Degradation)"},"_":"http://identifiers.org/sbo/SBO:0000029","vcid":"ReactionStep(EGFReceptor_Degradation)","qualifier":"(bio) is"},"$2ReactionStep(EGFReceptor_Degradation)":{"$":{"name":"ReactionStep(EGFReceptor_Degradation)"},"_":"urn:miriam:sbo:SBO%3A0000012","vcid":"ReactionStep(EGFReceptor_Degradation)","qualifier":"(model) isDescribedBy"},"$1ReactionStep(EGFReceptor_Production)":{"$":{"name":"ReactionStep(EGFReceptor_Production)"},"_":"urn:miriam:sbo:SBO%3A0000012","vcid":"ReactionStep(EGFReceptor_Production)","qualifier":"(model) isDescribedBy"}},"qualifier":""}}